Abano Healthcare Group Limited (NZX:ABA) advises that it has successfully
completed the shortfall bookbuild component of the $35 million capital raise
announced on 26 July 2017, with strong support from institutional and other
eligible investors.
The clearing price under the shortfall bookbuild was $9.25 per share, a
premium of $1.10 per share over the application price of $8.15 under the
offer. Therefore, eligible shareholders who did not take up their full
entitlements will receive $1.10 for each new share not taken up by them.
Payment is expected to be made on 1 September 2017.
Chairman of Abano, Mr Trevor Janes, commented: "We are pleased with the
support we have received from shareholders and the investment community. We
look forward to stepping up our growth plans in the trans-Tasman dental
market, particularly in Australia, as we focus on our goal of creating a
$1-billion revenue dental business".
The shares taken up under the offer are expected to be allotted and commence
trading on 30 August 2017.
End CA:00306276 For:ABA Type:OFFER Time:2017-08-28 14:35:20